Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:48 PM ET 8-K
Reverse Stock Split Jaguar Health, Inc. JAGX

Jaguar Health Reverse Stock Split

Jaguar Health, Inc. effected a 1-for-15 reverse stock split of its issued and outstanding common stock on September 17, 2026. Following the split, the company has approximately 520,088 shares of common stock outstanding. Additionally, the company filed a Certificate of Elimination to remove several series of preferred stock from its charter as no shares of those series remained outstanding.

4:48 PM ET Form 4
Insider Selling Urban Outfitters Inc URBN

Urban Outfitters Global CEO Anthropologie Group Tricia D. Smith Sells $266K of Stock

Tricia D. Smith, Global CEO Anthropologie Group, sold 3,500 shares of Urban Outfitters Inc at $75.95 a share, worth $266K in total on Sep 18, 2026. Shares held after the trade: 30,112 (-10.4%).

Value
$266K
Shares
3,500
Price
$75.95
Role
Global CEO Anthropologie Group
Holding change
-10.4%
Trade date
Sep 18, 2026
4:46 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.7M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $492.91 to $498.25 a share (average $494.79) in 6 transactions, worth $4.7M in total on Sep 18, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$4.7M
Shares
9,500
Average price
$494.79
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Sep 18, 2026
4:46 PM ET 8-K
Leadership Change Quanome Technologies, Inc. QNME

Quanome Technologies Leadership Change

Quanome Technologies announced that Ms. Xiaoou Li has resigned from the Board of Directors, and Ms. Chao Liu has been appointed as a new independent director to fill the vacancy. Ms. Liu will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, with compensation consistent with existing non-employee director policies.

4:46 PM ET Form 4
Insider Selling Fastly, Inc. FSLY

Fastly Principal Accounting Officer Jeffrey Ford Sells $1.13M of Stock

Jeffrey Ford, Principal Accounting Officer, sold 45,832 shares of Fastly, Inc. at $23.57 to $25.37 a share (average $24.65) in 3 transactions, worth $1.13M in total on Sep 17, 2026. Shares held after the trade: 249,861 (-2.5%).

Value
$1.13M
Shares
45,832
Average price
$24.65
Role
Principal Accounting Officer
Holding change
-2.5%
Trade date
Sep 17, 2026
4:46 PM ET Form 4
Insider Selling Fastly, Inc. FSLY

Fastly CTO Artur Bergman Sells $55.7K of Stock

Artur Bergman, CTO, sold 2,200 shares of Fastly, Inc. at $25.30 a share, worth $55.7K in total on Sep 17, 2026. Shares held after the trade: 1,595,006 (-0.1%).

Value
$55.7K
Shares
2,200
Price
$25.30
Role
CTO
Holding change
-0.1%
Trade date
Sep 17, 2026
4:46 PM ET Form 4
Insider Selling Fastly, Inc. FSLY

Fastly President, Go to Market Scott R. Lovett Sells $1.03M of Stock

Scott R. Lovett, President, Go to Market, sold 41,815 shares of Fastly, Inc. at $23.56 to $25.38 a share (average $24.64) in 3 transactions, worth $1.03M in total on Sep 17, 2026. Shares held after the trade: 1,281,583 (-0.4%).

Value
$1.03M
Shares
41,815
Average price
$24.64
Role
President, Go to Market
Holding change
-0.4%
Trade date
Sep 17, 2026
4:46 PM ET Form 4
Insider Selling Kanzhun Ltd BZ

Kanzhun CEO Peng Jonathan Zhao Sells $110M of Stock

Peng Jonathan Zhao, CEO, sold 15,170,000 shares of Kanzhun Ltd at $7.25 a share, worth $110M in total on Sep 21, 2026. Shares held after the trade: 110,996,801 (-8.8%).

Value
$110M
Shares
15,170,000
Average price
$7.25
Role
CEO
Holding change
-8.8%
Trade date
Sep 21, 2026
4:45 PM ET Form 4
Insider Buying Globalstar, Inc. GSAT

Globalstar Insider James Monroe III Buys $29.8M of Stock

James Monroe III bought 361,600 shares of Globalstar, Inc. at $82.52 a share, worth $29.8M in total on Sep 18, 2026. Shares held after the trade: 408,253 (+775.1%).

Value
$29.8M
Shares
361,600
Price
$82.52
Holding change
+775.1%
Trade date
Sep 18, 2026
4:43 PM ET 8-K
Dividend Monroe Capital Enhanced Corporate Lending Fund

Monroe Capital Enhanced Corporate Lending Fund Dividend

Monroe Capital Enhanced Corporate Lending Fund declared a monthly distribution of $0.187 per share for its Class I common shares, payable on October 22, 2026. The filing also provided a routine update on the fund's net asset value of $26.20 per share and its investment portfolio composition as of August 31, 2026.

4:42 PM ET 8-K
Leadership Change Trafalgar International, Inc. TRFA

Trafalgar International Leadership Change

Trafalgar International appointed Carlos Septién as Chief Executive Officer and to the Board of Directors, succeeding Porfirio Sanchez Talavera who resigned as CEO but remains Chairman. Mr. Septién previously served as the company's Chief Operating Officer and brings over 45 years of experience in the Mexican banking and financial services sectors. The transition follows a recent corporate name change and aligns with the company's strategy to focus on acquisitions in the financial services and technology sectors.

4:40 PM ET 8-K
Capital Raise Orion180 Insurance Group Inc. OIG

Orion180 Insurance Group Capital Raise of $240M

Orion180 Insurance Group Inc. completed its initial public offering (IPO) of 20,000,000 shares of Class A common stock at a price of $12.00 per share. The offering generated gross proceeds of $240.0 million and coincided with the appointment of five new directors to the company's board.

Value
$240M
4:37 PM ET 8-K
M&A Deal PTC Therapeutics, Inc. PTCT

PTC Therapeutics M&A Deal with Sangamo Therapeutics, Inc.

PTC Therapeutics has completed its acquisition of ST-920 (isaralgagene civaparvovec), a BLA-stage AAV gene therapy for Fabry disease, from Sangamo Therapeutics. The company expects to complete a rolling Biologics License Application (BLA) submission to the FDA for accelerated approval in the fourth quarter of 2026. The acquisition adds a potential one-time treatment for Fabry disease to PTC's rare disorder pipeline.

Counterparty
Sangamo Therapeutics, Inc.
4:37 PM ET Form 4
Insider Buying Skillsoft Corp. SKIL

Skillsoft CEO & Executive Chair Ronald W. Hovsepian Buys $99.9K of Stock

Ronald W. Hovsepian, CEO & Executive Chair, bought 15,468 shares of Skillsoft Corp. at $6.17 to $6.52 a share (average $6.46) in 2 transactions, worth $99.9K in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 362,746 (+3.7%).

Value
$99.9K
Shares
15,468
Average price
$6.46
Role
CEO & Executive Chair
Holding change
+3.7%
Trade date
Sep 17, 2026 to Sep 18, 2026
4:35 PM ET 8-K
Capital Raise PennantPark Private Income Fund

PennantPark Private Income Fund Capital Raise of $830K

PennantPark Private Income Fund issued and sold 32,047 common shares for aggregate proceeds of approximately $830,000. The sale was conducted as part of the company's ongoing continuous private offering to accredited investors.

Value
$830K
4:33 PM ET Form 4
Insider Buying Group 1 Automotive Inc GPI

Group 1 Automotive 10% Owner Conifer Management L.L.C. Buys $16.9M of Stock

Conifer Management L.L.C., 10% Owner, bought 65,650 shares of Group 1 Automotive Inc at $247.17 to $269.89 a share (average $256.78) in 16 transactions, worth $16.9M in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 1,475,153 (+0.0%).

Value
$16.9M
Shares
65,650
Average price
$256.78
Role
10% Owner
Holding change
+0.0%
Trade date
Sep 17, 2026 to Sep 18, 2026
4:32 PM ET Form 4
Insider Buying Corebridge Financial, Inc. CRBG

Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $6.15M of Stock

Nippon Life Insurance Co, 10% Owner, bought 174,760 shares of Corebridge Financial, Inc. at $35.20 a share, worth $6.15M in total on Sep 17, 2026. Shares held after the trade: 123,475,852 (+0.1%).

Value
$6.15M
Shares
174,760
Price
$35.20
Role
10% Owner
Holding change
+0.1%
Trade date
Sep 17, 2026
4:31 PM ET 8-K
Other 8-K Filing Integrated Wellness Acquisition Corp WELW

Integrated Wellness Acquisition Other 8-K Filing

Integrated Wellness Acquisition Corp held an extraordinary general meeting where shareholders approved an extension of the deadline to consummate an initial business combination from September 16, 2026, to March 16, 2027. In connection with the vote, shareholders redeemed 24,908 Class A ordinary shares, resulting in an expected withdrawal of approximately $0.33 million from the company's trust account.

4:31 PM ET Form 4
Insider Selling Dell Technologies Inc. DELL

Dell Technologies Director Silver Lake Technology Investors IV L.P. Sells $585K of Stock

Silver Lake Technology Investors IV L.P., Director, sold 998 shares of Dell Technologies Inc. at $581.52 to $591.24 a share (average $586.17) in 11 transactions, worth $585K in total on Sep 17, 2026. Shares held after the trade: 502 (-25.0%).

Value
$585K
Shares
998
Average price
$586.17
Role
Director
Holding change
-25.0%
Trade date
Sep 17, 2026
4:31 PM ET Form 4
Insider Selling Dell Technologies Inc. DELL

Dell Technologies Director Silver Lake Technology Investors V L.P. Sells $257K of Stock

Silver Lake Technology Investors V L.P., Director, sold 439 shares of Dell Technologies Inc. at $581.52 to $590.54 a share (average $586.03) in 10 transactions, worth $257K in total on Sep 17, 2026. Shares held after the trade: 226 (-24.9%).

Value
$257K
Shares
439
Average price
$586.03
Role
Director
Holding change
-24.9%
Trade date
Sep 17, 2026
4:31 PM ET Form 4
Insider Selling Gerdau S.A. GGB

Gerdau Insider Rafael Gamboa Lopes Sells $264K of Stock

Rafael Gamboa Lopes sold 51,800 shares of Gerdau S.A. at $5.09 a share, worth $264K in total on Sep 17, 2026. Shares held after the trade: 83,399 (-38.3%).

Value
$264K
Shares
51,800
Price
$5.09
Holding change
-38.3%
Trade date
Sep 17, 2026
4:31 PM ET 8-K
Other 8-K Filing Neonc Technologies Holdings, Inc. NTHI

Neonc Technologies Holdings Other 8-K Filing

NeOnc Technologies redeemed all 6,000 outstanding shares of its Series A Convertible Preferred Stock for approximately $5.79 million in cash. The redemption was funded by proceeds from a recent $15 million registered direct offering to eliminate potential dilution from the preferred stock's conversion features and simplify the company's capital structure.

4:31 PM ET 8-K
Shareholder Meeting Soligenix, Inc. SNGX

Soligenix Shareholder Meeting

Soligenix held its 2026 Annual Meeting of Stockholders where shareholders elected five directors and approved several key proposals. Major outcomes included the ratification of an increase in authorized common shares from 75 million to 125 million and the approval of a discretionary reverse stock split at a ratio between 1-for-2 and 1-for-20.

4:31 PM ET 8-K
Shareholder Meeting TurnOnGreen, Inc. TOGI

TurnOnGreen Shareholder Meeting

TurnOnGreen, Inc. held its 2026 Annual Meeting of Shareholders on September 18, 2026, where shareholders elected three directors and ratified CBIZ CPAs P.C. as the independent auditor. Shareholders also approved a 2026 Stock Incentive Plan and authorized the board to implement a reverse stock split at a ratio between 1-for-50 and 1-for-500 before December 31, 2028.

4:31 PM ET 8-K
M&A Deal Calisa Acquisition Corp ALIS

Calisa Acquisition M&A Deal with Goodvision AI Inc.

Calisa Acquisition Corp entered into a Prepaid Forward Purchase Agreement with Goodvision AI Inc. and Harraden Circle Investments to support its pending business combination. Under the agreement, the purchaser may acquire up to 3,000,000 ordinary shares to minimize redemptions and maximize cash retention upon the closing of the merger.

Counterparty
Goodvision AI Inc.
Term
12 months
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice BioCardia, Inc. BCDA

BioCardia Nasdaq/NYSE Compliance Notice

BioCardia has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its common stock closed at or above $1.00 per share for at least 10 consecutive business days. The company had previously received a deficiency notice on August 19, 2026, and Nasdaq has now officially closed the matter. The company's common stock will continue to trade on The Nasdaq Capital Market under the symbol 'BCDA'.

Counterparty
The NASDAQ Stock Market, LLC
4:31 PM ET 8-K
Leadership Change Wolverine World Wide Inc WWW

Wolverine World Wide Leadership Change

Wolverine World Wide, Inc. eliminated the position of President, Active Group, resulting in the departure of Susie Kuhn effective September 21, 2026. Ms. Kuhn's duties have been redistributed throughout the organization as part of this structural change.

Counterparty
Susie Kuhn
4:31 PM ET 8-K
M&A Deal Isabella Bank Corp ISBA

Isabella Bank M&A Deal with Grand River Commerce, Inc.

Isabella Bank Corporation announced that shareholders of Grand River Commerce, Inc. have approved the previously announced merger agreement between the two companies. The transaction, which involves the merger of Grand River into Isabella and their respective bank subsidiaries, is expected to close in the fourth quarter of 2026 subject to regulatory approvals.

Counterparty
Grand River Commerce, Inc.
4:30 PM ET 8-K
Regulatory Approval NewAmsterdam Pharma Co N.V. NAMS

NewAmsterdam Pharma Co Regulatory Approval

NewAmsterdam Pharma and its partner Menarini Group received European Commission marketing authorization for Ubeslo (obicetrapib) and Evlarco (obicetrapib/ezetimibe FDC) for the treatment of hypercholesterolaemia, marking the first regulatory approval for obicetrapib worldwide. The approval triggers milestone payments to NewAmsterdam in the mid-teens of millions of euros under its existing licensing agreement with Menarini. The company remains eligible for up to €833 million in total milestones plus tiered double-digit royalties on net sales in Europe.

Counterparty
Menarini Group

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.